Guangdong Hisilicon Medical Technology Co., Ltd., a China-based firm, has successfully raised nearly RMB 100 million (approximately USD 13.9 million) in a Series A financing round led by Qiaojing Capital. The funding round also attracted participation from notable investors including Hongcheng Investment, RongTong Capital, Chiron Ventures, and Zhejiang Innovation and Development Capital.
Founded in 2019, Hisilicon specializes in the research, development, and technological offerings of interventional medical devices tailored for special and complex lesions. The company holds three Category III device licenses in China for its disposable intravascular guide wire, hydrophilic guide wire, and guide wire, with a product portfolio that spans interventional applications in nerve, peripheral, and coronary arteries.- Flcube.com
